معرفی
Thomas P Green is a Professor in the Department of Pediatrics at Northwestern University's Feinberg School of Medicine, specializing in Pulmonary and Sleep Medicine. He maintains clinical appointments at Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern Memorial Hospital, with research affiliations at the Institute for Augmented Intelligence in Medicine, NUCATS, and Stanley Manne Children's Research Institute.
His educational background includes:
- MD from Stanford University (1974)
- MS in Pharmacy from University of Maryland School of Pharmacy (2016)
- Pediatrics Internship and Residency at University of Minnesota Medical Center (1975-1977)
- Fellowships in Clinical Pharmacology (1979) and Pediatric Pulmonology (1994) at University of Minnesota Medical Center, plus additional Pulmonology training at University of North Carolina School of Medicine (1994)
Dr. Green's research centers on pharmacometrics and pediatric clinical pharmacology, employing quantitative modeling and simulation to optimize drug therapy in children. His work addresses critical gaps in drug disposition, efficacy, and safety for pediatric populations, with emphasis on respiratory diseases, critical care applications, and pharmacokinetic challenges in special populations like obese children and neonates. This approach directly informs clinical trial design for pediatric therapeutics.
Recent publications (2023-2024) demonstrate consistent focus on pediatric pharmacokinetics through collaborative networks like the Best Pharmaceuticals for Children Act – Pediatric Trials Network, addressing real-world challenges in antibiotic stewardship, proton pump inhibitor dosing, and anticoagulant therapy for children with genetic variations and comorbidities.
His major honors include:
- Rho Chi Society Academic Honor (2016)
- Master of Critical Care designation from American College of Critical Care Medicine (2016)
- Posy and John Krehbiel Professorship at Lurie Children's Hospital (1998)
Dr. Green has held influential national leadership roles including Chair of the Publications Committee for the Pediatric Trials Network (NICHD), Chair of the Protocol Review Committee for the IDeA States Pediatric Clinical Trials Network (NIH), and service on the National Advisory Committee for the Collaborative Pediatric Critical Care Research Network (NICHD). These positions involve strategic oversight of multi-center clinical trials and research funding mechanisms across pediatric pharmacology and critical care.
He operates within the Pediatric Trials Network framework and contributes to the Institute for Augmented Intelligence in Medicine, focusing on translational applications of pharmacometric modeling to improve pediatric drug development and therapeutic decision-making.
